Clinical trial
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic…
NCT00180089 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00180089 |
|---|---|
| Title | Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation |
| Official title | Efficacy and Safety of Orale Budesonide in the Prevention of Acute Gastrointestinal Graft-versus-host Disease Following Allogenic Stem Cell Transplantation |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | Dr. Falk Pharma GmbH Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Graft-Versus-Host Disease |
| Intervention type | Drug |
| Interventions | Budesonide |
| Enrollment | 242 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 30, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: